4-aminopyridine has been researched along with Glucose Intolerance in 1 studies
Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Segal, JL | 1 |
| Thompson, JF | 1 |
| Tayek, JA | 1 |
1 trial available for 4-aminopyridine and Glucose Intolerance
| Article | Year |
|---|---|
Effects of long-term 4-aminopyridine therapy on glucose tolerance and glucokinetics in patients with spinal cord injury.
Topics: 4-Aminopyridine; Adult; Glucose; Glucose Intolerance; Glucose Tolerance Test; Hospitals, Veterans; H | 2007 |